Significance and Use
4.1 This practice provides guidance on sample size calculations and comparative statistical analysis. The purpose of this practice is to provide guidance on demonstrating that an implant under evaluation is statistically superior, equivalent, or not inferior to a reference implant for the specific performance criteria under evaluation.
4.1.1 The first pathway to determine the sample size for comparative testing starts with performing a pre-test sample size calculation. This calculation requires, in part, data for an implant for sample size calculation from which the required number of samples for comparative testing is calculated as described in Sections 7 , 8 , and 9 for superiority, equivalence, and non-inferiority testing respectively.
4.1.2 The second pathway allows the user to not perform a sample size calculation before comparative testing. Instead, the user performs comparative testing on a minimum of five specimens of the implant under evaluation and the reference implant and performs a statistical comparison to determine whether they meet the predetermined statistical acceptance criteria. If the comparison does not provide sufficient evidence to achieve statistical acceptance criteria, then further sample size calculations are required.
4.2 After following the first or second pathway, this practice provides guidance on how to statistically analyze the results from the comparative testing.
4.3 This practice provides guidance intended to address a wide variety of potential use scenarios. The four examples in X1.5 show how this practice may be applied in some simple scenarios.
Scope
1.1 This practice describes how to use existing data and statistical hypothesis testing principles to estimate the number of specimens needed to compare an implant under evaluation and a reference implant based on minimum criteria for Type I and Type II errors ( 6.1.1 , 6.1.2 ). This practice also describes the analysis of data obtained from comparative testing with statistical hypothesis testing principles to compare the data collected for the implant under evaluation and reference implant groups. This standard is only applicable for the comparison of two groups, that is, the implant under evaluation and reference implant groups.
1.2 This practice explicitly applies to arthroplasty implant test methods that generate measurable or quantitative values such as the following standardized test methods: F1820 , F1829 , F2009 , F2724 ; and ISO 7206-10, ISO 7206-12, and ISO 7206-13. This practice can be used for other test methods, if applicable.
1.3 This practice does not apply to the determination of the sample size for tests that generate only qualitative data, which cannot be estimated by measuring a quantitative value. Nor does it apply to fatigue testing, wear testing, or hip-impingement testing (Test Method F2582 ) which may require a different method to determine the appropriate number of specimens. It only applies to static testing with quantitative data of interest.
1.4 The requirements which are specified in this document are not intended to require the re-design or re-testing of implants that have been legally marketed and for which there is a history of sufficient and safe clinical use as defined in paragraph 3.15 of ISO 21535:2023. For such implants, compliance with this document can be demonstrated by providing evidence of the implant’s sufficient and safe clinical use.
1.5 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.